Kernodle & Katon Asset Management Group’s Usana Health Sciences USNA Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$0	Buy	+4	New	+$239	﹤0.01%	366

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Kernodle & Katon Asset Management Group's USNA Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group opened a new position in Usana Health Sciences (USNA) in Q1 2017: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #366 among its holdings.

155 funds tracked by Wall St. Rank hold USNA as of Q1 2017.

Kernodle & Katon Asset Management Group held 4 shares of Usana Health Sciences worth $0 as of Q1 2017.
Usana Health Sciences was a new Kernodle & Katon Asset Management Group position in Q1 2017.
Usana Health Sciences made up ﹤0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #366 holding.
155 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.